The Advanced Genomics Collaboration (TAGC)

The Advanced Genomics Collaboration (TAGC) is a pioneering partnership dedicated to advancing biotechnology research and driving innovation in precision medicine. Located in Melbourne, VIC, AU, TAGC’s mission is to leverage the power of genomics to create commercially successful biomedical projects and businesses that enhance healthcare accessibility and affordability. This collaboration between Illumina and The University of Melbourne provides researchers and innovators with access to cutting-edge genomic sequencing, advanced bioinformatics resources, and expert guidance in commercialization and health economics.

The Advanced Genomics Collaboration is a crucial hub within the Melbourne Biomedical Precinct, facilitating multi-disciplinary collaborations and accelerating the translation of genomic discoveries into tangible solutions. By providing access to Illumina’s expertise and state-of-the-art technology, TAGC empowers collaborators to develop groundbreaking therapies, diagnostics, and preventative measures.

TAGC is committed to fostering a thriving biotechnology ecosystem in Australia, driving economic growth, and ultimately improving health outcomes for all. The partnership is focused on enabling greater levels of genomics research and clinical trials, supporting the creation of a brighter future for healthcare. We invite the company’s management to create a customized and exclusive company showcase and product listing on our platform to further amplify your reach and impact.